The Impact of Antimicrobial Resistance on Co-INFECTIONS: Management Strategies for HIV, TB and Malaria

Abstract

Antimicrobial resistance is a growing global health problem, especially in the management of co-infections such as HIV, TB, and malaria. AMR occurs when a pathogen develops resistance against antimicrobial agents, which results in less effective treatments and contributes to increased morbidity and mortality. Co-infections further worsen this condition by introducing complex interactions among pathogens that complicate disease progression and treatment protocols. This review discusses the impact of AMR on co-infection from a multifaceted perspective, considering cases of HIV-TB, HIV-malaria, and TB-malaria. It considers the main factors contributing to the emergence and dissemination of resistant varieties: interactions between pathogens, horizontal gene transfer, and inappropriate antibiotic use. The study has highlighted that comprehensive management strategies, including antimicrobial stewardship, better diagnostics, vaccination, and addressing the basic underlying risks, such as poor sanitation and comorbid conditions, are urgently needed. Advanced diagnostic testing and strong infection control are crucial in lessening the burden of AMR. From a wider perspective, the paper calls for global collaboration in developing new antimicrobials and raising public awareness about using antibiotics judiciously. It concludes by stressing once more the need for integrating global health to address AMR and improve treatment outcomes to protect public health from the compounded threats of antimicrobial resistance and co-infections.